| Autor: |
Akseli Hemminki, Sari Pesonen, Aristides G. Eliopoulos, Angelica S.I. Loskog, Anna Kanerva, Suvi Parviainen, Simona Bramante, Saila K. Pesonen, Matteo Ugolini, Sophie Escutenaire, Mari L.M. Hirvinen, Vincenzo Cerullo, Iulia Diaconu |
| Rok vydání: |
2023 |
| Popis: |
PDF file - 881K, (A) Oncolytic potency of Ad5/3-hTERT-E1A-hCD40L and (B) Ad5/3-hTERT-E1A on EJ (CD40+) and A549 (CD40-). Cell lines were infected with Ad5/3Luc1, Ad5/3-hTERT-E1A, Ad5/3-hTERT-E1A-hCD40L and Ad5/3-CMV-hCD40L and cell viability was measured by MTS assay The assay was stopped 7 days after infection and the data was plotted to compare efficacy on CD40+ versus CD40- cells; Ad5/3-hTERT-E1A-hCD40L was more effective than the positive control on the former while the opposite was true for the latter. . VP=viral particles. ***, P |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
